CTOs on the Move

ActiveCare

www.activecare.com

 
ActiveCare, Inc. provides patented diabetes and chronic disease management and wellness solutions that increase visibility, lower costs and provide real-time care for members resulting in improved outcomes. Utilizing state-of-the-art meters with embedded cellular technology, trained CareSpecialists can intervene in real-time and provide members with the support needed to control their disease 24 hours a day, every day. ActiveCare's solution is revolutionizing the way employers, individuals and their health plans monitor chronic disease.  
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Amphora Medical Inc

Amphora Medical, located in Minneapolis, Minnesota, is a privately held bladder fulguration company

Dental Concepts

Dental Concepts is a Paramus, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WYTECH Industries Inc

WYTECH Industries Inc is a Rahway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rafi Systems Inc

Rafi Systems Inc is a Diamond Bar, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrity Applications

Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.